NFKB1 and early-onset autosomal dominant Alzheimer disease: NF-κB-mediated brain inflammation has been linked with both aging and neurodegenerative disorders [40,41], including Alzheimer’s disease (AD) [42], which is a progressive brain disorder that is most prevalent in individuals between 65 and 85 years old [43].